Federal contract award
75N98022F00064
NATIONAL INSTITUTE OF HEALTH (NIH), NATIONAL CANCER INSTITUTE (NCI), T VETERINARY CLINICAL TRIAL STUDY TO TEST COMBINATION ANTI-CANCER THERAPY FOR DOGS WITH NATURALLY OCCURRING MELANOMA S4 MSC TO# 176 NCI/CCR/LCBG
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH OLAO |
| NAICS | 541990 — All Other Professional, Scientific, and Technical Services |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | 75N98020D00086 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $182.8K |
| Current contract value | $182.8K |
| Potential contract value / ceiling | $334.4K |
| Start date | Sep 5, 2022 |
| Current end date | Mar 24, 2026 |
| Potential end date | Mar 24, 2026 |
| Latest award activity | Sep 12, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 12, 2025 | P00004 | $0 | NATIONAL INSTITUTE OF HEALTH (NIH), NATIONAL CANCER INSTITUTE (NCI), T VETERINARY CLINICAL TRIAL STUDY TO TEST COMBINATION ANTI-CANCER THERAPY FOR DOGS WITH NATURALLY OCCURRING MELANOMA S4 GHD TO# 176 NCI/CCR/LCBG |
| Jun 12, 2025 | P00003 | $31.3K | NATIONAL INSTITUTE OF HEALTH (NIH), NATIONAL CANCER INSTITUTE (NCI), T VETERINARY CLINICAL TRIAL STUDY TO TEST COMBINATION ANTI-CANCER THERAPY FOR DOGS WITH NATURALLY OCCURRING MELANOMA S4 GHD TO# 176 NCI/CCR/LCBG |
| Sep 24, 2024 | P00002 | $0 | NATIONAL INSTITUTE OF HEALTH (NIH), NATIONAL CANCER INSTITUTE (NCI), T VETERINARY CLINICAL TRIAL STUDY TO TEST COMBINATION ANTI-CANCER THERAPY FOR DOGS WITH NATURALLY OCCURRING MELANOMA |
| Aug 9, 2023 | P00001 | $0 | NATIONAL INSTITUTE OF HEALTH (NIH), NATIONAL CANCER INSTITUTE (NCI), T VETERINARY CLINICAL TRIAL STUDY TO TEST COMBINATION ANTI-CANCER THERAPY FOR DOGS WITH NATURALLY OCCURRING MELANOMA S4 MSC TO# 176 NCI/CCR/LCBG |
| Aug 31, 2022 | 0 | $151.6K | NATIONAL INSTITUTE OF HEALTH (NIH), NATIONAL CANCER INSTITUTE (NCI), T VETERINARY CLINICAL TRIAL STUDY TO TEST COMBINATION ANTI-CANCER THERAPY FOR DOGS WITH NATURALLY OCCURRING MELANOMA S4 MSC TO# 176 NCI/CCR/LCBG |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.